For CCL5, the levels of this gene in the HCC group (4.32 ± 4.81) were significantly different from the non-HCC (1.25 ± 4.46, P < 0.001) and healthy controls (0.00 ± 4.19, P < 0.001). The gene discussed is CCL5; the disease is hepatocellular carcinoma.